| Wal-mart Pharmacy 10-3574 | |
| 1520 E Exchange Pkwy, Allen, Texas 75002 | |
| (214) 547-8671 |
| Name | Wal-mart Pharmacy 10-3574 |
|---|---|
| Organization Name | Wal-mart Stores Texas Llc |
| Location | 1520 E Exchange Pkwy, Allen, Texas 75002 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (214) 547-8671 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A promising new study reports on the high neutralizing efficacy of a polyclonal swine antibody against SARS-CoV-2, the pathogen responsible for the novel COVID-19. By demonstrating the ability of this antibody to neutralize all currently circulating viral variants, the study suggests that it is ideal for development as a new and very effective therapy for COVID-19.
Babies born with Severe Combined Immune Deficiency (SCID) syndrome are defenceless against bacterial and viral infections that would be virtually harmless to most healthy people. If untreated, SCID is often fatal within a baby's first year of life.
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
A research group at Umeå University in Sweden has managed to capture and describe a protein structure that, until now, has been impossible to study. The discovery lays the base for developing designed enzymes as catalysts to new chemical reactions for instance in biotechnological applications.
› Verified 8 days ago
| NPI Number | 1669499711 |
| Organization Name | WAL-MART STORES TEXAS LLC |
| Doing Business As | WALMART PHARMACY 10-3574 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1520 E Exchange Pkwy, Allen, TX 75002 |
| Phone Number | 214-547-8671 |
News Archive
A promising new study reports on the high neutralizing efficacy of a polyclonal swine antibody against SARS-CoV-2, the pathogen responsible for the novel COVID-19. By demonstrating the ability of this antibody to neutralize all currently circulating viral variants, the study suggests that it is ideal for development as a new and very effective therapy for COVID-19.
Babies born with Severe Combined Immune Deficiency (SCID) syndrome are defenceless against bacterial and viral infections that would be virtually harmless to most healthy people. If untreated, SCID is often fatal within a baby's first year of life.
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
A research group at Umeå University in Sweden has managed to capture and describe a protein structure that, until now, has been impossible to study. The discovery lays the base for developing designed enzymes as catalysts to new chemical reactions for instance in biotechnological applications.
› Verified 8 days ago
News Archive
A promising new study reports on the high neutralizing efficacy of a polyclonal swine antibody against SARS-CoV-2, the pathogen responsible for the novel COVID-19. By demonstrating the ability of this antibody to neutralize all currently circulating viral variants, the study suggests that it is ideal for development as a new and very effective therapy for COVID-19.
Babies born with Severe Combined Immune Deficiency (SCID) syndrome are defenceless against bacterial and viral infections that would be virtually harmless to most healthy people. If untreated, SCID is often fatal within a baby's first year of life.
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
A research group at Umeå University in Sweden has managed to capture and describe a protein structure that, until now, has been impossible to study. The discovery lays the base for developing designed enzymes as catalysts to new chemical reactions for instance in biotechnological applications.
› Verified 8 days ago
Bioadvance Prosthetic Solutions Type: Medicare Supplier Location: 1111 Raintree Cir, Allen, Texas 75013 Phone: (972) 521-6101 | |
Cook Children's Home Health Type: Durable Medical Equipment & Medical Supplies Supplier Location: 13 Prestige Circle, Allen, Texas 75002 Phone: (214) 596-9508 | |
Cvs Pharmacy # 16585 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 907 W Mcdermott Dr, Allen, Texas 75013 Phone: (972) 396-0096 | |
Cvs Pharmacy # 17548 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 150 E Stacy Rd, Allen, Texas 75002 Phone: (469) 342-2005 | |